drugset / Trial / NCT01583816
Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis Lesions
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Dose-Finding Study of Resiquimod Evaluating Safety and Efficacy in Patients with Multiple Actinic Keratosis Lesions
Timeline
- Start
- 2012-05
- Primary completion
- 2013-11
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Resiquimod | Small molecule | 0.01 % | Topical |
| Subject | Resiquimod | Small molecule | 0.03 % | Topical |